Top

Published in:

01-05-2011

The molecular fingerprint of cardiac dyssynchrony and cardiac resynchronization therapy

Authors: Marc Vanderheyden, Chris Vrints, Jozef Bartunek

Published in: Heart Failure Reviews | Issue 3/2011

Abstract

To date, cardiac resynchronization therapy remains the only treatment that enhances systolic function while improving long-term outcome and survival. Here, we review the molecular alterations associated with dyssynchronous heart failure and their reversibility induced by cardiac resynchronization therapy. We focus upon the molecular portrait of dyssynchronous heart failure and how cardiac resynchronization therapy influences electrophysiologic, metabolic and adrenergic pathways.

Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, Gasparini M, Linde C, Morgado FB, Oto A, Sutton R, Trusz-Gluza M, European Society of Cardiology, European Heart Rhythm Association (2007) Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Europace 9(10):959–998

Nelson GS, Berger RD, Fetics BJ, Talbot M, Hare JM, Spinelli JC, Kass DA (2000) Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 102:3053–3059PubMed

Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L (2005) Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539–1549PubMedCrossRef

Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–1853PubMedCrossRef

Linde C, Leclercq Ch, Rex S, Garrigue S, Lavergne T, Cazeau S, McKenna W, Fitzgerald M, Deharo JC, Alonso C, Walker S, Braunschweig F, Bailleul C, Daubert JC (2002) Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STImulation in Cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 3(40):111–118

Spragg DD, Kass DA (2006) Pathobiology of left ventricular dyssynchrony and resynchronization. Prog Cardiovasc Dis 49(1):26–41PubMedCrossRef

Auricchio A, Stellbrink C, Block M, Sack S, Vogt J, Bakker P, Klein H, Kramer A, Ding J, Salo R, Tockman B, Pochet T, Spinelli J (1999) ffect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 99(23):2993–3001PubMed

Vanderheyden M, Bartunek J (2009) Cardiac resynchronization therapy in dyssynchronous heart failure: zooming in on cellular and molecular mechanisms. Circulation 119(9):1192–1194PubMedCrossRef

Van Oosterhout MF, Prinzen FW, Arts T, Schreuder JJ, Vanagt WY, Cleutjens JP, Reneman RS (1998) Asynchronous electrical activation induces asymmetrical hypertrophy of the left ventricular wall. Circulation 98(6):588–595PubMed

10.

Vernooy K, Verbeek XA, Peschar M, Crijns HJ, Arts T, Cornelussen RN, Prinzen FW (2005) Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion. Eur Heart J 26(1):91–98PubMedCrossRef

11.

Prinzen FW, Vernooy K, DeBoeck BWL, Delhaas T (in press) Mechanoenergetics of the asynchronous and resynchronized heart. Heart Fail Rev

12.

Vernooy K, Cornelussen RN, Verbeek XA, Vanagt WY, van Hunnik A, Kuiper M, Arts T, Crijns HJ, Prinzen FW (2007) Cardiac resynchronization therapy cures dyssynchronopathy in canine left bundle-branch block hearts. Eur Heart J 28(17):2148–2155PubMedCrossRef

13.

Leclercq C, Kass DA (2002) Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol 39(2):194–201PubMedCrossRef

14.

Gao Z, Barth AS, DiSilvestre D, Akar FG, Tian Y, Tanskanen A, Kass DA, Winslow RL, Tomaselli GF (2008) Key pathways associated with heart failure development revealed by gene networks correlated with cardiac remodeling. Physiol Genomics 35(3):222–230PubMedCrossRef

15.

Spragg DD, Leclercq C, Loghmani M, Faris OP, Tunin RS, DiSilvestre D, McVeigh ER, Tomaselli GF, Kass DA (2003) Regional alterations in protein expression in the dyssynchronous failing heart. Circulation 108:929–932PubMedCrossRef

16.

Baller D, Wolpers HG, Zipfel J, Bretschneider HJ, Hellige G (1988) Comparison of the effects of right atrial, right ventricular apex and atrioventricular sequential pacing on myocardial oxygen consumption and cardiac efficiency: a laboratory investigation. Pacing Clin Electrophysiol 11(4):394–403PubMedCrossRef

17.

Boerth RC, Covell JW (1971) Mechanical performance and efficiency of the left ventricle during ventricular stimulation. Am J Physiol 221(6):1686–1691PubMed

18.

Bahler RC, Martin P (1985) Effects of loading conditions and inotropic state on rapid filling phase of left ventricle. Am J Physiol 48(42):523–533

19.

Owen CH, Esposito DJ, Davis JW, Glower DD (1998) The effects of ventricular pacing on left ventricular geometry, function, myocardial oxygen consumption, and efficiency of contraction in conscious dogs. Pacing Clin Electrophysiol 21(7):1417–1429PubMedCrossRef

20.

Leclercq C, Gras D, Le Helloco A, Nicol L, Mabo P, Daubert C (1995) Hemodynamic importance of preserving the normal sequence of ventricular activation in permanent cardiac pacing. Am Heart J 129(6):1133–1141PubMedCrossRef

21.

Auricchio A, Prinzen FW (2008) Update on the pathophysiological basics of cardiac resynchronization therapy. Europace 10(7):797–800PubMedCrossRef

22.

Mills RW, Cornelussen RN, Mulligan LJ, Strik M, Rademakers LM, Skadsberg ND, van Hunnik A, Kuiper M, Lampert A, Delhaas T, Prinzen FW (2009) Left ventricular septal and left ventricular apical pacing chronically maintain cardiac contractile coordination, pump function and efficiency. Circ Arrhythm Electrophysiol 2(5):571–579PubMedCrossRef

23.

Leclercq C, Faris O, Tunin R, Johnson J, Kato R, Evans F, Spinelli J, Halperin H, McVeigh E, Kass DA (2002) Systolic improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left bundle-branch block. Circulation 106(14):1760–1763PubMedCrossRef

24.

Prinzen FW, Peschar M (2002) Relation between the pacing induced sequence of activation and left ventricular pump function in animals. Pacing Clin Electrophysiol 25(41):484–498PubMedCrossRef

25.

Kass DA (2009) Pathobiology of cardiac dyssynchrony and resynchronization. Heart Rhythm 6(11):1660–1665PubMedCrossRef

26.

Sengupta PP, Tondato F, Khandheria BK, Belohlavek M, Jahangir A (2008) Electromechanical activation sequence in normal heart. Heart Fail Clin 4(3):303–314PubMedCrossRef

27.

Aiba T, Hesketh GG, Barth AS, Liu T, Daya S, Chakir K, Dimaano VL, Abraham TP, O’Rourke B, Akar FG, Kass DA, Tomaselli GF (2009) Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy. Circulation 119(9):1220–1230PubMedCrossRef

28.

Zabel M, Koller BS, Sachs F, Franz MR (1996) Stretch-induced voltage changes in the isolated beating heart: importance of the timing of stretch and implications for stretch-activated ion channels. Cardiovasc Res 32(1):120–130PubMed

29.

Spragg DD, Akar FG, Helm RH, Tunin RS, Tomaselli GF, Kass DA (2005) Abnormal conduction and repolarization in late-activated myocardium of dyssynchronously contracting hearts. Cardiovasc Res 67(1):77–86PubMedCrossRef

30.

Chakir K, Daya SK, Tunin RS, Helm RH, Byrne MJ, Dimaano VL, Lardo AC, Abraham TP, Tomaselli GF, Kass DA (2008) Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization. Circulation 117(11):1369–1377PubMedCrossRef

31.

D’Ascia C, Cittadini A, Monti MG, Riccio G (2006) Saccà effects of biventricular pacing on interstitial remodelling, tumor necrosis factor-alpha expression, and apoptotic death in failing human myocardium. Eur Heart J 27(2):201–206PubMedCrossRef

32.

Bilchick KC, Saha SK, Mikolajczyk E, Cope L, Ferguson WJ, Yu W, Girouard S, Kass DA (2006) Differential regional gene expression from cardiac dyssynchrony induced by chronic right ventricular free wall pacing in the mouse. Physiol Genomics 26(2):109–115PubMedCrossRef

33.

Barth AS, Aiba T, Halperin V, DiSilvestre D, Khalid C, Dimaano VL, Yu W, Abraham T, Kass D, Tomaselli GF (2008) Cardiac resynchronization therapy corrects dyssynchrony-induced regional gene expression changes on a genomic level. Circulation 118:S_531

34.

Mullens W, Bartunek J, Wilson Tang WH, Delrue L, Herbots L, Willems R, De Bruyne B, Goethals M, Verstreken S, Vanderheyden M (2008) Early and late effects of cardiac resynchronization therapy on force-frequency relation and contractility regulating gene expression in heart failure patients. Heart Rhythm 5(1):52–59PubMedCrossRef

35.

Vanderheyden M, Mullens W, Delrue L, Goethals M, Verstreken S, Wijns W, De Bruyne B, Bartunek J (2008) Endomyocardial upregulation of betal adrenoreceptor gene expression and myocardial contractile reserve following cardiac resynchronization therapy. J Card Fail 14:172–178PubMedCrossRef

36.

Chakir K, Daya SK, Aiba T, Tunin RS, Dimaano VL, Abraham TP, Lai EW, Pacak K, Zhu W, Xiao R, Tomaselli GF, Kass DA (2009) Mechanisms of enhanced beta-adrenergic reserve from cardiac resynchronization therapy. Circulation 119:1231–1240PubMedCrossRef

37.

De Sousa E, Veksler V, Minajeva A, Kaasik A, Mateo P, Mayoux E, Hoerter J, Bigard X, Serrurier B, Ventura-Clapier R (1999) Subcellular creatine kinase alterations. Implications in heart failure. Circ Res 85(1):68–76PubMed

38.

Knaapen P, van Campen LM, Götte MJ, Visser CA, Lammertsma AA, Visser FC (2004) Effects of cardiac resynchronization therapy on myocardial perfusion reserve. Circulation 110(6):646–651PubMedCrossRef

39.

Agnetti G, Kaludercic N, Kane LA, Elliott ST, Guo Y, Chakir K, Samantapudi D, Paolocci N, Tomaselli GF, Kass DA, Van Eyk JE (2010) Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts. Circ Cardiovasc Genet 3(1):78–87PubMedCrossRef

40.

Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsan J 3rd, St John Sutton M, De Sutter J, Murillo J (2008) Results of the predictors of response to CRT (PROSPECT) trial. Circulation 117(20):2608–2616PubMedCrossRef

41.

Abraham T, Kass D, Tonti G, Tomassoni GF, Abraham WT, Bax JJ, Marwick TH (2009) Imaging cardiac resynchronization therapy. JACC Cardiovasc Imaging 2(4):486–497PubMedCrossRef

42.

Iyengar S, Haas G, Lamba S, Orsinelli DA, Babu GJ, Ferketich AK, Yamokoski L, Periasamy M, Abraham WT (2007) Effect of cardiac resynchronization therapy on myocardial gene expression in patients with nonischemic dilated cardiomyopathy. J Card Fail 13(4):304–311PubMedCrossRef

43.

Vanderheyden M, Mullens W, Delrue L, Goethals M, De Bruyne B, Wijns W, Geelen P, Verstreken S, Wellens F, Bartunek J (2008) Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders. J Am Coll Cardiol 51(2):129–136PubMedCrossRef

Title: The molecular fingerprint of cardiac dyssynchrony and cardiac resynchronization therapy
Authors: Marc Vanderheyden
Chris Vrints
Jozef Bartunek
Publication date: 01-05-2011
Publisher: Springer US
Published in: Heart Failure Reviews / Issue 3/2011
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-010-9199-x

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

The molecular fingerprint of cardiac dyssynchrony and cardiac resynchronization therapy

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2011

Mechano-energetics of the asynchronous and resynchronized heart

Chronic ventricular pacing in children: toward prevention of pacing-induced heart disease

Past, present, and future of CRT

When is an optimization not an optimization? Evaluation of clinical implications of information content (signal-to-noise ratio) in optimization of cardiac resynchronization therapy, and how to measure and maximize it

Atrioventricular and interventricular delay optimization in cardiac resynchronization therapy: physiological principles and overview of available methods

Current and future role of cardiovascular magnetic resonance in cardiac resynchronization therapy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page